Véronique Loustaud Ratti

Véronique Loustaud Ratti

Université de Limoges - Limoges / France
Medical and Health Sciences / Gastroenterology
AD Scientific Index ID: 918189
University of Limoges
person_outline Véronique Loustaud Ratti's MOST POPULAR ARTICLES
1-) Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Etude et de Recherche en …P Cacoub, C Renou, E Rosenthal, P Cohen, I Loury, V Loustaud-Ratti, ...Medicine 79 (1), 47-56, 20007662000
2-) Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort studyF Carrat, H Fontaine, C Dorival, M Simony, C Hezode, V De Ledinghen, ...The Lancet 393 (10179), 1453-1464, 20195552019
3-) Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)–NCT01514890C Hézode, H Fontaine, C Dorival, D Larrey, F Zoulim, V Canva, ...Journal of hepatology 59 (3), 434-441, 20135552013
4-) Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trialsSA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ...Journal of hepatology 73 (1), 26-39, 20203822020
5-) Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a …M Bourlière, JP Bronowicki, V De Ledinghen, C Hézode, F Zoulim, ...The Lancet Infectious Diseases 15 (4), 397-404, 20153732015